Recent Finacing
Recent Raise
NextWave Pharmaceuticals develops and commercializes cardiovascular and CNS therapies using proprietary drug‑delivery technology, has launched NEXICLON XR extended‑release clonidine and is developing ER liquid methylphenidate.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
